These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis. Lindberg J, Stenling R, Palmqvist R, Rutegård J. J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208 [Abstract] [Full Text] [Related]
5. Risk of colorectal cancer in ulcerative colitis in India. Venkataraman S, Mohan V, Ramakrishna BS, Peter S, Chacko A, Chandy G, Kurian G, Kurian S, Mathan M, Mathan VI, Patra S, Pulimood A, Rolston DD. J Gastroenterol Hepatol; 2005 May; 20(5):705-9. PubMed ID: 15853982 [Abstract] [Full Text] [Related]
6. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB. Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704 [Abstract] [Full Text] [Related]
7. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH. Scand J Gastroenterol; 2009 Jun; 44(1):46-55. PubMed ID: 18609187 [Abstract] [Full Text] [Related]
8. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. Velayos FS, Loftus EV, Jess T, Harmsen WS, Bida J, Zinsmeister AR, Tremaine WJ, Sandborn WJ. Gastroenterology; 2006 Jun; 130(7):1941-9. PubMed ID: 16762617 [Abstract] [Full Text] [Related]
9. Is colonoscopy alone sufficient to screen for ulcerative colitis-associated colorectal carcinoma? Bruewer M, Krieglstein CF, Utech M, Bode M, Rijcken E, Anthoni C, Laukoetter MG, Schuermann G, Senninger N. World J Surg; 2003 May; 27(5):611-5. PubMed ID: 12715233 [Abstract] [Full Text] [Related]
11. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study. Terg R, Sambuelli A, Coronel E, Mazzuco J, Cartier M, Negreira S, Muñoz A, Gil A, Miguez C, Huernos S, Romero G, Goncalvez S, Levi D, Abecasis R. Acta Gastroenterol Latinoam; 2008 Mar; 38(1):26-33. PubMed ID: 18533354 [Abstract] [Full Text] [Related]
12. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis. Rubin DT, LoSavio A, Yadron N, Huo D, Hanauer SB. Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1346-50. PubMed ID: 17059900 [Abstract] [Full Text] [Related]
13. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Shetty K, Rybicki L, Brzezinski A, Carey WD, Lashner BA. Am J Gastroenterol; 1999 Jun; 94(6):1643-9. PubMed ID: 10364038 [Abstract] [Full Text] [Related]